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INTRODUCTION
Acquired Immuno Deficiency Syndrome (AIDS), is
a clinical syndrome (a group of various illnesses that
together characterize a disease) that results from
damage to the immune system caused by infection
with the human immunodeficiency virus . The
current definition of acquired immune deficiency
syndrome (AIDS) include individuals who test
positive for human immune deficiency virus (HIV)
and have a CD4 (cluster of differentiation antigen) T
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cell number of less than 200/mm (the normal count is
600 1000/mm ) of whole blood or a CD4 T cell
number of 200/mm .
In addition, there is presence of opportunistic
diseases such as fungal diseases including
candidiasis, coccidioidomycosis, cryptococcosis, or
toxoplasmosis of the brain. Others are bacterial
diseases including pulmonary tuberculosis and other
spp infections or recurrent
salmonella septicemia, as well as diseases including
cytomegalovirus infections, chronic ulcers or
bronchitis due to herpes simplex or progressive
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: Fungal infections are common complications of AIDS and pulmonary complications remain a
major cause of both morbidity and mortality in immunocompromised patients. Such complications can also
result in life threatening meningitis and discomforting if not debilitating thrush. The impact of the Acquired
Immunodeficiency Syndrome (AIDS) on the incidence of mycoses is difficult to predict but is likely to be
substantial. Retrospective studies in Africa and USA have indicated that 58% to 81% of patients with AIDS
develop a mycosis.
The objectives of the study were to determine the prevalence of pulmonary mycosis in AIDS
patients with complications of cough, determine if there is any relationship between AIDS and pulmonary
mycoses and determine if there is any difference in the prevalence of pulmonary mycoses in AIDS patients on
anti retroviral drugs and those not on drugs.
A total of 195 sputum samples were obtained from patients diagnosed with full blown Acquired
Immune Deficiency Syndrome (AIDS) who had been sick between 6 months to 3 yrs with CD4 count less than
200/mm presenting with cough at the University of Benin Teaching Hospital (UBTH) Edo State. 55 (28.2%) of
population studied had been on anti-retroviral medication, with the remainder on none during the study period.
Forty other sputum samples were obtained from apparently healthy (HIV Seronegative) persons also based in
Benin City as controls. All subjects were grouped into <20 (3.1%), 20-30 (32.3%), 31-40 (30.3%), 41-50
(17.4%), 51(2.1%) age groups. Test and control samples were cultured on Sabouraud Dextrose Agar and
Potato Dextrose Agar and incubated at 37 C and room temperatures respectively with daily observation for
growth for 2 weeks. Cultural and morphological characteristics, KOH mount and Lactophenol Cotton Blue
staining were used to identify opportunistic fungal pathogens.
: One hundred and forty (71.8%) of test samples yielded fungal pathogens while 55(28.2%) yielded no
growth. 3(7.5%) of control samples yielded fungal growth. Fungal organisms isolated were:
(19.0%), (9.7%), (9.7%), (9.7%),
(5.6%), spp (7.2%), (4.1%), (3.6%) and
spp (3.1%) in that order. All (9) organisms were isolated from patients within 21-30 and 31-40 age
groups; 8 organisms from 41-50 age group and 3 organisms each from 20 and 50 age brackets.
and occurred in all age groups.
Findings suggest that routine management (treatment) of pulmonary opportunistic mycoses in
AIDS patients should include treatment for Candidiasis and Cryptococcosis for all age groups as well as
additional antifungal agents if patients fall within 21-45 age group.






studies in Africa and USA have indicated that 58% to
81% of patients withAIDS develop a mycosis .
The most common is oral candidiasis which can
begin during the AIDS related complex (ARC) or
later. Cryptococcosis is a potentially lethal infection
which has occurred in roughly 6 8% of patients in the
United States . If this prevalence rate is current, the
actual incidence of this mycosis should be at least
double in the United States, compared to the decade
prior to AIDS. Although mycoses exhibit an
extraordinary heterogeneity, they have certain
features in common. Infection is usually acquired
from nature, not from infected humans or animals.
Certain types of ringworm and candidiasis are
notable entry points for systemic mycoses.
Systemic mycoses are fungal infections which
involve deep organs. While some often referred to as
the endemic mycoses infect healthy individuals,
others are opportunistic infections which occur in
patients with some underlying predisposition. In
recent years, systemic mycoses such as
cryptococcosis and histoplasmosis have become
prominent as secondary complications in patients
with AIDS, although it is of interest that other
systemic mycoses have not increased in this
population. Generally, while in most developed
countries, the opportunistic infections are seen more
commonly, the endemic fungal infections are seen
more frequently in the tropical areas .
Four stages are recognized in the progression of HIV
d i s e a s e a n d t h e s e a r e : p r i m a r y
infection/seroconversion, clinically latent period,
early HIV disease and late HIV disease/AIDS. In
advanced HIV disease with severe immuno
suppression, there is a decrease in the number of CD4
T cells to below 400 cells/ml (the normal CD4 cell
count in HIV negative adult is about 1000 cell/ml .At
CD4 T cell level below 200 cells/ml, fungal diseases
including: candidiasis, coccidioidomycosis,
cryptococcosis, histoplasmosis, pulmonary
aspergillosis, penicillosis and pneumocystis
pneumonia are often found in such patients. In a
healthy immuno competent individual, these fungal
pathogens do not pose any problem because they are
always countered by the host immune mechanism.
The destruction of the host immune mechanism in
AIDS patients makes the affected individual
vulnerable to non opportunistic organisms as those
responsible for the diseased conditions mentioned
above. Pulmonary mycoses are common diseases
associated with HIV/AIDS patients .
The aim of this research is to study pulmonary
mycoses incidence in patients with acquired
immunodeficiency diseases with the following
objectives:
(a) To determine the prevalence of pulmonary






such as invasive lymphoma . Besides, some other
diseases which may be overlooked, but require
consideration, include those caused by
,
and measles virus .
The end result of HIV infection is that CD4 cells
progressively decline in number. This has serious
health consequences. In a normal human, CD4 cells
constitute about 70% of the total T cell pool. In
AIDS patients, the number of CD4 cells steadily
decreases and by the time opportunistic infections
set in, CD4 cell may be almost absent. As CD4 cells
decline in number, there is a concomitant loss in the
cytokines they produce. Since cytokines influence
the production and maturation of other lymphocytes,
this leads to the gradual reduction of uninfected T-
cells and eventually, all other lymphocytes, thus
shutting down the immune system in those suffering
from clinical AIDS. This loss of both humoral and
cellular immune function is readily apparent in the
opportunistic infections observed. Systemic
infections by fungi and Mycobacteria point to a loss
in TH1 cellular immunity. Other opportunistic
infections such as the various viral and bacterial
infections associated with AIDS, indicate the loss of
humoral immunity. Decline in antibody production
is due to the loss of TH2 cells necessary to stimulate
antibody production by Beta cells.
The overall picture of AIDS progression indicates
that during the clinical latency period, a very active
infectious process is proceeding. First, there is an
intense immune response to HIV of which about 1
billion virions are destroyed each day and HIV
number drops. However, this means that HIV is
replicating at a very high rate and this replication
results in the corresponding destruction of about
100million CD4 T cells each day. Eventually, the
immune response is simply overwhelmed, HIV
levels increase and the T cells are finally completely
destroyed thus crippling the immune responses and
allowing the emergence of opportunistic infections .
Fungi are well recognized causes (among others), of
opportunistic diseases in most, if not all full blown
AIDS cases. Most of the diseases they cause (which
are superficial), include dermatophytosis (skin, nail
and hair infections) and candidiasis. However,
extreme deforming and potentially fatal deep
systemic infections can also occur . Fungal
infections are common complications of AIDS and
pulmonary complications remain a major cause of
b o t h m o r b i d i t y a n d m o r t a l i t y i n
immunocompromised patients . Such complications
can also result in life threatening meningitis and
discomforting if not debilitating thrush. The impact
of the Acquired Immunodeficiency Syndrome
(AIDS) on the incidence of mycoses is difficult to






Strongyloides stercoralis Pseudomonas aeruginosa
Nigerian Journal of Clinical Practice March 2010, Vol.13(1) Pulmonary Mycoses Aluyi et al 79
samples were inoculated on the SDA and PDA media
and streaked out to obtain discrete colonies. These
plates were then incubated at both room temperature
and at 37 C the incubator. Plates were incubated at
room temperature and 37 C to aid growth of
dimorphic fungi i.e. those that grow as yeasts
(parasitic phase) at 37 C and as moulds (saprophytic
phase) at room temperature. Cultures were observed
daily for growth for 2 weeks. Gross colonial
morphology, colour and texture of the colony surface
and underside which can be very distinctive were
observed.
A drop of sodium hydroxide (20% w/v) solution was
placed on a slide. An aliquot of each sputum sample
was transferred to the drop of sodium hydroxide on
the side and this was covered with a glass cover slip.
This was then allowed to stay for 5-10 mins to enable
it to clear, after which it was examined
microscopically using X40 objective. Characteristic
morphological elements such as nature and form of
microconidia, macrocondia, spherule, fruiting
bodies, sporangium, encapsulated cells, budding
cells and broad based cyst, spherical fish like yeast
cells were observed.
Direct microscopy of culture isolates was also done.
A drop of lactophenol cotton blue was placed on
grease free slide and a fraction of culture was
transferred to drop of lactophenol cotton blue on the
slide and covered with a glass cover slip. This was
then examined microscopically using the X10 and
X40 objectives with the condenser iris diaphragm
closed sufficiently to give good contrast. Structures
such as spherules, microconidia, pseudohyphae,
encapsulated cells, sporangia were noted.
Human Serum (0.5ml) was pipetted into a small test
tube. Using a sterile wire loop, the serum was
inoculated with a yeast colony from the culture. The
tube was placed in an incubator at 37 c for 2-3 hrs.
With the aid of a Pasteur pipette, a drop of the serum
yeast culture was transferred to a glass slide and
covered with a coverslip. This was then examined
using the X10 and X40 objectives.










Certain yeasts develop special fruiting forms (called
chlamydospores) when grown in glucose free
medium like Rice Agar. Isolates identified as yeasts
were inoculated onto prepared sterile rice agar plates
and incubated at room temperature for 24 48 hrs and
observed for pseudomycelia and chlamydospore
development.
Candida albicans (20.5%),
Formation of Pseudomycelia and Chlamydospores
(B) Determine if there is any relationship between
AIDS and Pulmonary mycoses.
(C) Determine if there is any difference in the
prevalence of pulmonary mycoses in AIDS patients
on antiretroviral drugs and those not on Drugs.
One hundred and ninety five (195) sputum samples
were collected from patients diagnosed with
HIV/AIDS and presenting with cough at the
University of Benin Teaching Hospital, Edo State,
Nigeria. 40 other samples were obtained from
apparently healthy persons based in Benin City, Edo
State capital. All sputum samples were collected
with sterile screw caped plastic containers. Out of
the 195 samples, 32 were obtained from patients
who were on anti-retroviral therapy. To obtain good
samples, sterile screw capped plastic containers
were given out to patients a day prior to sample
collection. Patients were instructed to cough out
sputum upon waking up into the containers and
bring them along to clinic same day. Samples were
collected from patients and sent immediately to the
laboratory for culture and direct microscopy.
Patient's biodata were obtained from them by oral
questioning.
Primary identification of these opportunistic fungal
organisms was based on their cultural characteristics
on Potato Dextrose Agar (PDA) and Sabouraud
Dextrose Agar (SDA). These characteristics
included the colour, colonial morphology, texture,
colony surface and underside. Others were germ
tube production, formation of pseudomycelia and
chlamydospores.
Although this study was centred on HIV/AIDS
patients, not all of them were eligible for sampling.
Because of the difficulty in generating sputum, only
debilitated patients that had persistent cough and
were positive for tuberculosis (i.e Acid Fast Bacilli
positive) as obtained from biodata were sampled
while AIDS patients who had no cough and were
negative forAFB were excluded.
Sterile Sabouraud Dextrose Agar (SDA) and Potato
Dextrose Agar (PDA) were prepared (according to
manufacturers instruction), sterilized by
autoclaving at 121psi for 15mins, allowed to cool
and while in molten form, modified by addition of
0.4g of chloramphenicol, 20,000 units of penicillin
and 4,000 units of streptomycin sulphate each added
to a litre of molten agar which was then dispensed
into sterile Petri dishes, allowed to set and stored in
the refrigerator. A plate of each medium was
incubated at 37 C for 24hrs to check for purity.
With the aid of a sterile wire loop, the sputum
MATERIALSAND METHODS
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and 6(3.1%) respectively. The least occurring
organisms in this age group were
and spp 1 (0.5%) each (Table 1).
The 51 age group patients yielded the least fungal
isolates of which occurred highest
with 2(1.0%) (Table 1). On the whole,
occurred highest across the whole age





7(3.6%) and 6(3.1%) in that order
(Table 1).
The occurrence of opportunistic pulmonary mycoses
was higher in females 86(44.1%) than in males
80(41.0%) of which within the female patients, the
highest occurrence was in the age group 21-30. The
lowest occurrence was recorded in the 51 age group.













Penicillium marneffei Rhodotorula rubra
Fusarium spp
Candida albicans Cryptococcus neoformans




Candida Stellatoidea (9.2%), Cryptococcus
neoformans (9.2%), Candida parapsilosis (8.2%),
Torulopsis glabrata (7.7%), Mucor spp (7.2%),
Penicillium marneffei (4.1%), Rhodotorula rubra
(3.1%) and Fusarium spp (2.1%)
Candida stellatoidea






in that order (Table
1). Of the 195 samples, 163(83.6%) produced fungal
growth while the remaining 32(16.4%) samples
(from patients on anti retroviral therapy), yielded no
growth after two weeks of incubation. Three out of
the 40 control samples (HIV Seronegative patients)
yielded growth of fungal organisms.
The incidence of pulmonary mycoses was highest in
the age group 21-30 with 63 isolates. Of these
isolates, had the highest
occurrence of 10(5.1%) followed closely by
and
with 9(4.6%) each. The least occurring organisms
within the group were and
spp with 2 (1.0%) occurrences. The 31-40
age bracket had the next highest incidence of
pulmonary mycoses with 59 isolates of which
had the highest occurrence of
12(6.2%) followed by and
having occurrence of 8(4.2%)
Table 1: Age Distribution of Opportunistic Fungal Infections among HIV/AIDS Patients.
Table 2: Age and Sex Distribution of Opportunistic Fungal Pathogens among HIV/AIDS Patients on

























 20 6 4(2.1%) 0(0.0) 1(0.5%) 1(0.0) 0(0.0) 0(0.0%) 0(0.0) 0(0.0) 1(0.5%)
21– 30 63 9(4.6%) 10(5.1%) 9(4.6%) 6(3.1%) 4(2.1%) 7(3.6%) 4(2.1%) 2(1.0%) 2(1.0%)
31– 40 59 12((.2%) 6(3.1%) 4(2.1%) 8(4.2%) 4(2.1%) 4(2.1%) 1(0.5%) 5(2.6%) 1(0.5%)
41 – 50 34 10(5.1%) 3(1.5%) 4(2.1%) 3(1.5%) 3(1.5%) 3(1.5%) 2(1.0%) 0(0.0%) 2(1.0%)
 51 4 2(1.0%) 0(0.0%) 1(0.5%) 1(0.5%) 0(0.0) 0(0.0) 1(0.5%) 0(0.0) 0(0.0)
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paranasal, pulmonary or disseminated infection in
those with reduced host defenses as inAIDS patients.
has recorded an incidence of
3.6%. Golden . reported its isolation in patients
with meningitis, endocarditis and sepsis. It is an
unusual opportunistic mycosis .
which showed an occurrence of 5.6%, is one of the
unusual fungal pathogens rarely isolated and finally
which are well known as plant
pathogens, showed an occurrence of 3.1%. This
organism is involved in secondary infection of the
lungs of tubercular or immunocompromised
patients .
Patients within the age group of 21-30 recorded the
highest incidence of pulmonary mycoses. The most
probable reason may be due on the way to the high
activity of patients in this age bracket and being that
AIDS takes 5-10 years to manifest, HIV infection
must have been acquired much earlier in life. Patients
who had been sick between 1 3 years seemed to have
more incidences of mycoses than those just entering
theAIDS phase from HIV with few months of illness.
This is quite expected because years into the AIDS
phase, nearly, if not all the immunity and immune
system would have been paralyzed thus making
patients highly vulnerable to infection by
opportunistic mycoses.
There was a high incidence of pulmonary mycoses in
HIV/AIDS patients than in apparently healthy
individuals as 163 (83.6%) of patients sampled had
fungal infection of the upper and lower respiratory
tracks. FemaleAIDS patients had higher incidence of
opportunistic mycoses than males and patients with
longer duration of illness in AIDS phase showed
higher incidence of mycoses.
Acquired Immune Deficiency Syndrome.
O n l i n e E n c y c l o p e d i a . M i c r o s o f t
Corporation. 2006 Microsoft Corporation.
Centre for Disease Control and Prevention.
Update on AIDS among patients with
hemophilia. MMWR. 1992; 31: 644 - 647.
Communi ty acqui red pneumonia in
immunocompromised patients. Postgraduate
Medicine. 2003; 113 (1): 65-77.
Brock
Biology of Microorganisms.9 edn. Prentice













3. Cebular S, Lee S, Tolaney P, Lutwick L.
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DISCUSSION
Of the nine fungal isolates, spp,
are known fungal pathogens
of man irrespective of the immunological status of
man. Female patients occurring in the age group 20
30 who had been sick for 2yrs had the highest
occurrence of fungal organisms while the least
occurred in 51 age group patients who had been
sick for 6 months. In the male patients, the highest
fungal occurrence was in the 31-40 age group
patients who had been ill for 10 months (Table 2).
, which generally are not common pathogens in
immunnocompetent individuals, may become
pathogenic in immunnocompromised individuals
(as inAIDS patients).
Opportunistic fungal infections are usually
associated with human Immunodeficiency virus and
acquired immunodeficiency syndrome . Out of the
195 sputum samples obtained from AIDS patients
with symptoms of cough, 163 (83.6%) of them
produced fungal growth. The remaining 32 samples
that produced no fungal growth were from patients
on anti-retroviral drugs. The absence of fungal
growth is due to Anti Retroviral Drug (ARD)
therapy, which points to the effectiveness of these
drugs in checking HIV/AIDS.
especially were
the highest implicated fungal pathogens. Generally,
is the most common causative agent of
opportunitistic fungal infections in HIV/AIDS
patients . Candidal infection of the oesophagus,
trachea, bronchi or lungs are recognized as indicator
diseases of AIDS. Baily reported that the
incidence of overall rates of candidiasis of the
esophagus and respiratory tract among patients
infected with HIV is as high as 30-40%. This is
similar to our finding of 38.4%. The occurrence of
was found to be 9.7%
among samples investigated. Infection rates of this
organism in the tropics are not known but it appears
to be variable even in patients with AIDS . Also,
there is evidence that in Zaire, about 12% of those
with AIDS have circulating Cryptococcus antigen
indicating active infection while in Great Britain, it
has been reported to occur in 3.8% of AIDS
patients . Dismusks reported that the incidence of
Cryptococcus in AIDS patients in United State of
America ranges from 6% to 12%.
in this study, shows an incidence of 4.1%
much lower than the findings of Supratinyo .
who reported an incidence of 10% of this organism
inAIDS patients in Hong Kong. Intense global travel
could be responsible for its spread to Nigeria.
had an occurrence of 7.2%. According to
Cheesbrough , Mucor infection causes severe
Candida
Cryptococcus neoformans, Mucor spp, and
Penicillium marneffei
Torulopsis spp, Rhadotorula rubra and Fusarium
spp
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